{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:29:49Z","timestamp":1782937789033,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472015"],"award-info":[{"award-number":["81472015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670927"],"award-info":[{"award-number":["31670927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Technological Innovation Platform Fund","award":["2014Y2101"],"award-info":[{"award-number":["2014Y2101"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jviromet.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T14:00:32Z","timestamp":1478268032000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen"],"prefix":"10.1016","volume":"240","author":[{"given":"Huang","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jinjie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Shengxiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tingdong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Xiaoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Tong-Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2016.11.001_bib0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1743-422X-6-45","article-title":"Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies","volume":"6","author":"Burbelo","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/JVI.01818-08","article-title":"Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages","volume":"83","author":"Chevillotte","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.vaccine.2014.03.057","article-title":"Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"32","author":"Fu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2016.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1099\/vir.0.19055-0","article-title":"Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells","volume":"84","author":"Gerna","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"La Rosa","year":"2012","journal-title":"Future Virol."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0050","first-page":"578","article-title":"Construction and application of an Escherichia coli high effective expression vector with an enhancer","volume":"16","author":"Luo","year":"2000","journal-title":"Sheng wu gong cheng xue"},{"key":"10.1016\/j.jviromet.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0010-4825(00)00006-8","article-title":"A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement","volume":"30","author":"Mackinnon","year":"2000","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The silent global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee","volume":"39","author":"Mordin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0075","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0141-0229(00)00185-X","article-title":"Electroelution as a simple and fast protein purification method: isolation of an extracellular xylanase from Bacillus sp CCMI 966","volume":"27","author":"Sa-Pereira","year":"2000","journal-title":"Enzyme Microb. Tech."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0085","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1016\/j.vaccine.2011.08.086","article-title":"A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines","volume":"29","author":"Tang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2016.11.001_bib0090","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","article-title":"Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome","volume":"78","author":"Varnum","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.11.001_bib0095","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","article-title":"Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2016.11.001_bib0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1386-6532(99)00060-8","article-title":"Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens","volume":"14","author":"Weber","year":"1999","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093415300938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093415300938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T20:22:17Z","timestamp":1536265337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093415300938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":20,"alternative-id":["S0166093415300938"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.11.001","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}